Author:
Kasper S,Zivkov M,Roes K.C.B,Pols A.G
Subject
Pharmacology (medical),Biological Psychiatry,Psychiatry and Mental health,Clinical Neurology,Neurology,Pharmacology
Reference52 articles.
1. American Psychiatric Association (1980) Diagnostic and Statistical Manual of Mental Disorders, 3 ed. American Psychiatric Association, Washington DC.
2. Anderson, I.M. and Tomenson, B.M. (1994) The efficacy of selective scrotonin re-uptake inhibitors in depression: a meta-analysis of studies against tryciclic antidepressants. J. Psychopharmacol. 8, 238–249.
3. Bakish, D. (1991) Fluoxetine potentiation by buspirone: Three case histories. Can. J. Psychiatry. 31, 749–750.
4. Bech, P., Gram, L.F., Dein, O., Jacobsen, O., Vitger, J. and Bolwig T.G. (1975) Quantitative rating of depressive states. Acta Psychiat. Scand. 51, 161–170.
5. Bremner, J.D. (1995) A double-blind comparison of Org 3770, amitriptyline and placebo in major depression. J. Clin. Psychiatry 56, 519–526.
Cited by
31 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献